Jubilant Pharmova posts 14% revenue jump in FY26, flags Montreal drag on margins

Jubilant Pharmova reports 14% revenue growth in FY26, driven by strong performance in sterile injectables despite margin pressures.

Raccontata dathehindubusinessline.com